Besides, the amount of CTGF mRNA and protein may change in cancerous tissue during tumor development, and it is not known whether this is a growth advantage for cancer cells or rather the reaction from stromal cells in order to inhibit the proliferation and metastasis (Kikuchi et al. 2007). Here, CCN2 is linked to cancer.